Clover Health Investments (CLOV) Competitors

Essent Group (NYSE:ESNT) and Clover Health Investments (NASDAQ:CLOV) are both insurance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

Which has higher valuation & earnings, ESNT or CLOV?

Essent Group has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Essent Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Essent Group	$1.29B	4.41	$729.40M	$6.83	8.20
Clover Health Investments	$1.37B	1.15	-$43.01M	-$0.05	-62.20

Which has more volatility and risk, ESNT or CLOV?

Essent Group has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 1.86, suggesting that its stock price is 86% more volatile than the S&P 500.

Does the media refer more to ESNT or CLOV?

In the previous week, Essent Group had 1 more articles in the media than Clover Health Investments. MarketBeat recorded 8 mentions for Essent Group and 7 mentions for Clover Health Investments. Essent Group's average media sentiment score of 0.87 beat Clover Health Investments' score of 0.31 indicating that Essent Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Essent Group	4 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Clover Health Investments	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend ESNT or CLOV?

Essent Group presently has a consensus price target of $63.71, suggesting a potential upside of 13.83%. Clover Health Investments has a consensus price target of $4.83, suggesting a potential upside of 55.41%. Given Clover Health Investments' stronger consensus rating and higher possible upside, analysts plainly believe Clover Health Investments is more favorable than Essent Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Essent Group	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
Clover Health Investments	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Is ESNT or CLOV more profitable?

Essent Group has a net margin of 57.29% compared to Clover Health Investments' net margin of -1.69%. Essent Group's return on equity of 12.98% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Essent Group	57.29%	12.98%	10.28%
Clover Health Investments	-1.69%	-7.42%	-4.00%

Do institutionals and insiders believe in ESNT or CLOV?

93.0% of Essent Group shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 2.9% of Essent Group shares are held by company insiders. Comparatively, 24.1% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Essent Group beats Clover Health Investments on 11 of the 16 factors compared between the two stocks.